Elizabeth A. Harley

Statistics

Publications

Citations

773

H-Index

Active since

1988

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Servier (France)

MSD (UK) Limited (United Kingdom)

Laboratoire de Mathématiques Analyse, Probabilités, Modélisation Orléans

Institut des Hautes Études Scientifiques

Elizabeth A. Harley is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and receptor pharmacology.

Publications per year

1988–2016

Publications

Novel quinuclidine-based ligands for the muscarinic cholinergic receptor

John Saunders, Stephen B. Freedman, Elizabeth A. Harley et al. · Journal of Medicinal Chemistry · 1990 · 158 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo‐M ratio as an index of efficacy at cortical muscarinic receptors

Stephen B. Freedman, Elizabeth A. Harley, Leslie L. Iversen · British Journal of Pharmacology · 1988 · 109 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans

Frédéric De Ceuninck, Catherine Kargar, C Ilić et al. · British Journal of Pharmacology · 2012 · 74 citations

Medicine, Endocrinology, Pharmacology +17

Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants

Patricia Rueda, Elizabeth A. Harley, Yao Wei Lu et al. · PLoS ONE · 2016 · 66 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Muscarinic M1, M2 receptor binding. Relationship with functional efficacy

Stephen B. Freedman, Margaret S. Beer, Elizabeth A. Harley · European Journal of Pharmacology · 1988 · 62 citations

Medicine, Pharmacology, Molecular Pharmacology +15

1–5 of 16